Preparation of HL-60 cell vaccine expressing BCG-HSP70 and its anti-leukemia effect
LI Xiaoling1, LIU Chunlei2, SUN Lirong3
(1. Department of the Third Pediatrics, the Linyi People's Hospital, Linyi 276000, Shandong, China; 2. Department of the Network and Data Center, the Linyi People's Hospital, Linyi 276000, Shandong, China; 3. Department of Pediatric Hematology, the Affiliated Hospital of Medical College, Qingdao University; Qingdao 266003, Shandong, China)
[1] Pui CH,Robison LL,Look AT. Acute lymphoblastic leukemia [J]. Lancet,2008,371(9617):1030-1043. [2] Pui CH,Carroll WL,Meshinchi S,et al. Biology,risk stratification,and therapy of pediatric acute leukemia:an update [J]. J Clin Oncol,2011,29(5):551-565. [3] Stow P,Key L,Chen X,et al. Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia [J]. Blood,2010,115(23):4657-4663. [4] Yang J,Sun LR,Pang XY,et al. Effect of Bacillus Calmette-Guerin on the expansion of dendritic cells from peripheral blood of pediatric patients with leukemia in vitro [J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi,2010,18(5):1240-1243. [5] Peng ML,Chen M,Ling NX,et al. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70 [J]. Vaccine,2006,24(7):887-896. [6] Wei MQ,Menoesha A,Good D,et al. Bacterial targeted tumor therapy-drawn of new era [J]. Cancer Lett,2008,259(1):16-27. [7] Ye J,Chen GS,Song HP,et al. Heat shock protein 70/MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo [J]. Cancer Immunol Immunother,2004,53(9):825-834. [8] Zhang Y,Li ZJ,Ma ZH,et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene [J]. Cancer Res,2000,60(4):1035-1042. [9] Onishi H,Kuroki H,Matsumoto K,et al. Monocyte-derived dendritic cells that capture dead tumor cells secret IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappa B autocrine loop [J]. J Cancer Immunol Immunother,2004,53(12):1093-1100. [10] Cheng WF,Hung CF,et al. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene [J]. J Immunol,2001,166(10):6218-6226. [11] Hsu KF,Hung CF,Cheng WF,et al. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen [J]. Gene Them,2001,8(5):376-383. [12] June CH. Adoptive T cell therapy for cancer in the clinic [J]. J Clin Invest,2007,117(6):1466-1476. [13] Ahmad M,Rees RC,Ali SA. Escape from immunotherapy possible mechanisms that influence tumor regression/ progression [J]. Cancer Immunol Immunother,2004,53(10):844-854. [14] Rouas - Freis N,Moreau P,Menier C,et al. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor response [J]. Semin Cancer Biol,2007,17(6):413-421. [15] Peng ML,Chen M,Ling N,et al. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein [J]. Vaccine,2006,24(7):887-896. [16] Mizukami S,Kajiwara C,Ishikawa H,et al. Both CD4+ and CD8+ T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors [J]. Cancer Sci,2008,99(5):1008-1015. [17] Murshid A,Gong J,Calderwook SK. Heat-shock proteins in cancer vaccines:agents of antigen cross-presentatio [J]. Expert Rev Vaccines,2008,7(7):1019-1030. [18] Yamaoka A,Guan X,Takemoto S. Development of a novel Hsp70-based DNA vaccine as a multifunction antigen delivery system [J]. J Control Release,2010,142(3):411-415. [19] Hockertz S. Present and future of cancer vaccines [J]. Toxicology,2005,214(1-2):151-161. [20] Venken K,Thewissen M,Hellings N,et al. A CFSE based assay for measuring CD4+ CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses [J]. J Immunol Methods,2007,322(1-2):1-11. [21] Tsuge I,Okumura A,Kondo Y,et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay [J]. Allergol Int,2007,56(2):149-155. [22] Placek K,Coffre M,Maiella S,et al. Genetic and epigenetic networks controlling T helper 1 cell differentiation [J]. Immunology,2009,127(2):155-162. [23] Weidnann E,Brieger J,Jahn B,et al. Lactate dehydrogenase release assay:a reliable nonradioactive technique for analysis of cytotoxic lymphocyte-mediate lytic activity against blasts from acute myelocytic leukemia [J]. Ann Hematol,1995,70(3):153-158. [24] Pirious L,Chilmonczyk S,Genetetet N,et al. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species [J]. Cytometry,2000,41(4):289-297.